Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Evolv Technologies Holdings, Inc.EVLV · Entity 5017 | Director | August 17, 2026 | August 19, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Evolv Technologies Holdings, Inc.
Report date August 17, 2026 · Filed August 19, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 2,083,961 |
Ending reported balance
After 2026-08-17 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-08-17 · Exercise / conversion · Acquired 80,752 · Balance 2,164,713 Row 2 · 2026-08-17 · Sale · Disposed 80,752 · Balance 2,083,961 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on June 12, 2025. F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.24 · Expires 2027-09-13 | Direct | 816,262 |
Reported balance
After 2026-08-17 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-08-17 · Exercise / conversion · Disposed 80,752 · Balance 816,262 F3: The option vested and became exercisable as to 25% on January 31, 2018 and vested in 36 equal monthly installments thereafter. |
| Class A Common StockSEC Table I · non-derivative | IndirectHeld by Family Horizon Trust | 151,135 |
Reported balance
Holding disclosure · report date 2026-08-17 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 151,135 |
Filing footnotes · ownership attribution and instrument terms
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on June 12, 2025.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
F3: The option vested and became exercisable as to 25% on January 31, 2018 and vested in 36 equal monthly installments thereafter.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 17, 2026 Filed Aug 19, 2026 20:08 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionStock Option (Right to Buy) · Derivative | 80,752 | $0.00 Strike: $0.24 | $0.00 |
DisclosureSEC source: 0001869206-26-000022 · wk-form4_1787170117.xml · derivative · entry 4 Ellenbogen Michael · CIK 0001869206 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 816,262 Underlying: Class A Common Stock · 80,752 shares Expires 2027-09-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested and became exercisable as to 25% on January 31, 2018 and vested in 36 equal monthly installments thereafter. Read SEC document |
| August 17, 2026 Filed Aug 19, 2026 20:08 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | SaleClass A Common Stock | 80,752 | $5.59 | $451,403.68 |
DisclosureSEC source: 0001869206-26-000022 · wk-form4_1787170117.xml · nonDerivative · entry 2 Ellenbogen Michael · CIK 0001869206 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,083,961 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on June 12, 2025. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 17, 2026 Filed Aug 19, 2026 20:08 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionClass A Common Stock | 80,752 | $0.24 | $19,380.48 |
DisclosureSEC source: 0001869206-26-000022 · wk-form4_1787170117.xml · nonDerivative · entry 1 Ellenbogen Michael · CIK 0001869206 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,164,713 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 15, 2026 Filed Jul 17, 2026 20:03 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionStock Option (Right to Buy) · Derivative | 80,745 | $0.00 Strike: $0.24 | $0.00 |
DisclosureSEC source: 0001869206-26-000020 · wk-form4_1784318611.xml · derivative · entry 4 Ellenbogen Michael · CIK 0001869206 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 897,014 Underlying: Class A Common Stock · 80,745 shares Expires 2027-09-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested and became exercisable as to 25% on January 31, 2018 and vested in 36 equal monthly installments thereafter. Read SEC document |
| July 15, 2026 Filed Jul 17, 2026 20:03 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | SaleClass A Common Stock | 80,745 | $5.94 | $479,625.30 |
DisclosureSEC source: 0001869206-26-000020 · wk-form4_1784318611.xml · nonDerivative · entry 2 Ellenbogen Michael · CIK 0001869206 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,083,961 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on June 12, 2025. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| July 15, 2026 Filed Jul 17, 2026 20:03 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionClass A Common Stock | 80,745 | $0.24 | $19,378.80 |
DisclosureSEC source: 0001869206-26-000020 · wk-form4_1784318611.xml · nonDerivative · entry 1 Ellenbogen Michael · CIK 0001869206 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,164,706 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 18, 2026 Filed Jun 22, 2026 20:02 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | GrantRestricted Stock Units · Derivative | 28,318 | $0.00 | $0.00 |
DisclosureSEC source: 0001869206-26-000018 · wk-form4_1782158565.xml · derivative · entry 1 Ellenbogen Michael · CIK 0001869206 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,318 Underlying: Class A Common Stock · 28,318 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A common stock. The RSUs have no expiration date. F2 · derivative.exercise_date: The RSUs will vest in full at the earlier of June 18, 2027 or the day immediately preceding the Issuer's next annual meeting date. F1 · derivative.expiration_date: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A common stock. The RSUs have no expiration date. Read SEC document |
| June 15, 2026 Filed Jun 16, 2026 20:06 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionStock Option (Right to Buy) · Derivative | 80,745 | $0.00 Strike: $0.24 | $0.00 |
DisclosureSEC source: 0001869206-26-000016 · wk-form4_1781640408.xml · derivative · entry 4 Ellenbogen Michael · CIK 0001869206 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 977,759 Underlying: Class A Common Stock · 80,745 shares Expires 2027-09-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested and became exercisable as to 25% on January 31, 2018 and vested in 36 equal monthly installments thereafter. Read SEC document |
| June 15, 2026 Filed Jun 16, 2026 20:06 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | SaleClass A Common Stock | 80,745 | $6.21 | $501,426.45 |
DisclosureSEC source: 0001869206-26-000016 · wk-form4_1781640408.xml · nonDerivative · entry 2 Ellenbogen Michael · CIK 0001869206 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,083,961 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on June 12, 2025. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 15, 2026 Filed Jun 16, 2026 20:06 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionClass A Common Stock | 80,745 | $0.24 | $19,378.80 |
DisclosureSEC source: 0001869206-26-000016 · wk-form4_1781640408.xml · nonDerivative · entry 1 Ellenbogen Michael · CIK 0001869206 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,164,706 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 15, 2026 Filed May 18, 2026 20:03 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionStock Option (Right to Buy) · Derivative | 80,745 | $0.00 Strike: $0.24 | $0.00 |
DisclosureSEC source: 0001869206-26-000014 · wk-form4_1779134608.xml · derivative · entry 4 Ellenbogen Michael · CIK 0001869206 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,058,504 Underlying: Class A Common Stock · 80,745 shares Expires 2027-09-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested and became exercisable as to 25% on January 31, 2018 and vested in 36 equal monthly installments thereafter. Read SEC document |
| May 15, 2026 Filed May 18, 2026 20:03 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | SaleClass A Common Stock | 80,745 | $5.63 | $454,594.35 |
DisclosureSEC source: 0001869206-26-000014 · wk-form4_1779134608.xml · nonDerivative · entry 2 Ellenbogen Michael · CIK 0001869206 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,083,961 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on June 12, 2025. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.53 to $5.77. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 15, 2026 Filed May 18, 2026 20:03 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionClass A Common Stock | 80,745 | $0.24 | $19,378.80 |
DisclosureSEC source: 0001869206-26-000014 · wk-form4_1779134608.xml · nonDerivative · entry 1 Ellenbogen Michael · CIK 0001869206 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,164,706 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 15, 2026 Filed Apr 17, 2026 20:05 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionStock Option (Right to Buy) · Derivative | 80,745 | $0.00 Strike: $0.24 | $0.00 |
DisclosureSEC source: 0001869206-26-000012 · wk-form4_1776456351.xml · derivative · entry 4 Ellenbogen Michael · CIK 0001869206 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,139,249 Underlying: Class A Common Stock · 80,745 shares Expires 2027-09-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested and become exercisable as to 25% on January 31, 2018 and vested in 36 equal monthly installments thereafter. Read SEC document |
| April 15, 2026 Filed Apr 17, 2026 20:05 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | SaleClass A Common Stock | 80,745 | $6.32 | $510,308.40 |
DisclosureSEC source: 0001869206-26-000012 · wk-form4_1776456351.xml · nonDerivative · entry 2 Ellenbogen Michael · CIK 0001869206 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,083,961 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on June 12, 2025. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.27 to $6.39. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 15, 2026 Filed Apr 17, 2026 20:05 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionClass A Common Stock | 80,745 | $0.24 | $19,378.80 |
DisclosureSEC source: 0001869206-26-000012 · wk-form4_1776456351.xml · nonDerivative · entry 1 Ellenbogen Michael · CIK 0001869206 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,164,706 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 06, 2026 Filed Mar 9, 2026 20:07 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | SaleClass A Common Stock | 91,771 | $5.10 | $468,032.10 |
DisclosureSEC source: 0001869206-26-000010 · wk-form4_1773086843.xml · nonDerivative · entry 1 Ellenbogen Michael · CIK 0001869206 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,083,961 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on June 12, 2025. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.04 to $5.17. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 02, 2026 Filed Mar 3, 2026 21:34 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | SaleClass A Common Stock | 82,913 | $5.19 | $430,318.47 |
DisclosureSEC source: 0001869206-26-000008 · wk-form4_1772573691.xml · nonDerivative · entry 4 Ellenbogen Michael · CIK 0001869206 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,175,732 F1 · shares: The sale reported in the Form 4 was effected solely with the intent to cover withholding taxes in connection with the vesting of RSUs. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.19 to $5.29. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 21:34 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionRestricted Stock Units · Derivative | 50,505 | $0.00 | $0.00 |
DisclosureSEC source: 0001869206-26-000008 · wk-form4_1772573691.xml · derivative · entry 8 Ellenbogen Michael · CIK 0001869206 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 101,010 Underlying: Class A Common Stock · 50,505 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A common stock. The RSUs have no expiration date. F6 · derivative.exercise_date: The RSUs vest in three equal annual installments commencing on March 1, 2026. F3 · derivative.expiration_date: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A common stock. The RSUs have no expiration date. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 21:34 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionRestricted Stock Units · Derivative | 57,392 | $0.00 | $0.00 |
DisclosureSEC source: 0001869206-26-000008 · wk-form4_1772573691.xml · derivative · entry 7 Ellenbogen Michael · CIK 0001869206 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,392 Underlying: Class A Common Stock · 57,392 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A common stock. The RSUs have no expiration date. F5 · derivative.exercise_date: The RSUs vest in three equal annual installments commencing on March 1, 2025. F3 · derivative.expiration_date: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A common stock. The RSUs have no expiration date. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 21:34 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionRestricted Stock Units · Derivative | 66,787 | $0.00 | $0.00 |
DisclosureSEC source: 0001869206-26-000008 · wk-form4_1772573691.xml · derivative · entry 6 Ellenbogen Michael · CIK 0001869206 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 66,787 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A common stock. The RSUs have no expiration date. F4 · derivative.exercise_date: The RSUs vest in three equal annual installments commencing on March 1, 2024. F3 · derivative.expiration_date: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A common stock. The RSUs have no expiration date. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 21:34 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionClass A Common Stock | 66,787 | $0.00 | $0.00 |
DisclosureSEC source: 0001869206-26-000008 · wk-form4_1772573691.xml · nonDerivative · entry 3 Ellenbogen Michael · CIK 0001869206 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,258,645 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 21:34 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionClass A Common Stock | 50,505 | $0.00 | $0.00 |
DisclosureSEC source: 0001869206-26-000008 · wk-form4_1772573691.xml · nonDerivative · entry 2 Ellenbogen Michael · CIK 0001869206 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,191,858 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 21:34 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionClass A Common Stock | 57,392 | $0.00 | $0.00 |
DisclosureSEC source: 0001869206-26-000008 · wk-form4_1772573691.xml · nonDerivative · entry 1 Ellenbogen Michael · CIK 0001869206 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,141,353 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 17, 2026 Filed Feb 18, 2026 21:57 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionStock Option (Right to Buy) · Derivative | 80,745 | $0.00 Strike: $0.24 | $0.00 |
DisclosureSEC source: 0001869206-26-000006 · wk-form4_1771451851.xml · derivative · entry 4 Ellenbogen Michael · CIK 0001869206 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,219,994 Underlying: Class A Common Stock · 80,745 shares Expires 2027-09-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested and became exercisable as to 25% on January 31, 2018 and vested in 36 equal monthly installments thereafter. Read SEC document |
| February 17, 2026 Filed Feb 18, 2026 21:57 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | SaleClass A Common Stock | 80,745 | $5.47 | $441,675.15 |
DisclosureSEC source: 0001869206-26-000006 · wk-form4_1771451851.xml · nonDerivative · entry 2 Ellenbogen Michael · CIK 0001869206 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,083,961 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on June 12, 2025. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.39 to $5.65. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 17, 2026 Filed Feb 18, 2026 21:57 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionClass A Common Stock | 80,745 | $0.24 | $19,378.80 |
DisclosureSEC source: 0001869206-26-000006 · wk-form4_1771451851.xml · nonDerivative · entry 1 Ellenbogen Michael · CIK 0001869206 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,164,706 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 16, 2026 Filed Jan 20, 2026 21:20 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionStock Option (Right to Buy) · Derivative | 80,745 | $0.00 Strike: $0.24 | $0.00 |
DisclosureSEC source: 0001869206-26-000004 · wk-form4_1768943997.xml · derivative · entry 4 Ellenbogen Michael · CIK 0001869206 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,300,739 Underlying: Class A Common Stock · 80,745 shares Expires 2027-09-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested and became exercisable as to 25% on January 31, 2018 and vested in 36 equal monthly installments thereafter. Read SEC document |
| January 16, 2026 Filed Jan 20, 2026 21:20 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | SaleClass A Common Stock | 80,745 | $6.20 | $500,619.00 |
DisclosureSEC source: 0001869206-26-000004 · wk-form4_1768943997.xml · nonDerivative · entry 2 Ellenbogen Michael · CIK 0001869206 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,083,961 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on June 12, 2025. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.13 to $6.37. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 16, 2026 Filed Jan 20, 2026 21:20 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionClass A Common Stock | 80,745 | $0.24 | $19,378.80 |
DisclosureSEC source: 0001869206-26-000004 · wk-form4_1768943997.xml · nonDerivative · entry 1 Ellenbogen Michael · CIK 0001869206 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,164,706 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 21:07 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | GrantRestricted Stock Units · Derivative | 3,731 | $0.00 | $0.00 |
DisclosureSEC source: 0001869206-26-000002 · wk-form4_1767733670.xml · derivative · entry 1 Ellenbogen Michael · CIK 0001869206 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,731 Underlying: Class A Common Stock · 3,731 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A common stock. The RSUs have no expiration date. F2 · derivative.exercise_date: The RSUs will vest in full on December 31, 2026. F1 · derivative.expiration_date: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A common stock. The RSUs have no expiration date. Read SEC document |
| December 15, 2025 Filed Dec 16, 2025 21:09 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionStock Option (Right to Buy) · Derivative | 80,745 | $0.00 Strike: $0.24 | $0.00 |
DisclosureSEC source: 0001869206-25-000013 · wk-form4_1765919350.xml · derivative · entry 4 Ellenbogen Michael · CIK 0001869206 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,381,484 Underlying: Class A Common Stock · 80,745 shares Expires 2027-09-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested and became exercisable as to 25% on January 31, 2018 and vested in 36 equal monthly installments thereafter. Read SEC document |
| December 15, 2025 Filed Dec 16, 2025 21:09 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | SaleClass A Common Stock | 80,745 | $6.91 | $557,947.95 |
DisclosureSEC source: 0001869206-25-000013 · wk-form4_1765919350.xml · nonDerivative · entry 2 Ellenbogen Michael · CIK 0001869206 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,083,961 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on June 12, 2025. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.75 to $7.20. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 15, 2025 Filed Dec 16, 2025 21:09 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionClass A Common Stock | 80,745 | $0.24 | $19,378.80 |
DisclosureSEC source: 0001869206-25-000013 · wk-form4_1765919350.xml · nonDerivative · entry 1 Ellenbogen Michael · CIK 0001869206 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,164,706 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 17, 2025 Filed Nov 18, 2025 21:02 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionStock Option (Right to Buy) · Derivative | 80,745 | $0.00 Strike: $0.24 | $0.00 |
DisclosureSEC source: 0001869206-25-000011 · wk-form4_1763499748.xml · derivative · entry 4 Ellenbogen Michael · CIK 0001869206 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,462,229 Underlying: Class A Common Stock · 80,745 shares Expires 2027-09-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested and became exercisable as to 25% on January 31, 2018 and vested in 36 equal monthly installments thereafter. Read SEC document |
| November 17, 2025 Filed Nov 18, 2025 21:02 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | SaleClass A Common Stock | 80,745 | $5.80 | $468,321.00 |
DisclosureSEC source: 0001869206-25-000011 · wk-form4_1763499748.xml · nonDerivative · entry 2 Ellenbogen Michael · CIK 0001869206 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,083,961 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on June 12, 2025. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.69 to $5.99. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 17, 2025 Filed Nov 18, 2025 21:02 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionClass A Common Stock | 80,745 | $0.24 | $19,378.80 |
DisclosureSEC source: 0001869206-25-000011 · wk-form4_1763499748.xml · nonDerivative · entry 1 Ellenbogen Michael · CIK 0001869206 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,164,706 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 15, 2025 Filed Oct 17, 2025 20:52 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionStock Option (Right to Buy) · Derivative | 80,745 | $0.00 Strike: $0.24 | $0.00 |
DisclosureSEC source: 0001869206-25-000009 · wk-form4_1760734338.xml · derivative · entry 4 Ellenbogen Michael · CIK 0001869206 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,542,974 Underlying: Class A Common Stock · 80,745 shares Expires 2027-09-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested and became exercisable as to 25% on January 31, 2018 and vested in 36 equal monthly installments thereafter. Read SEC document |
| October 15, 2025 Filed Oct 17, 2025 20:52 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | SaleClass A Common Stock | 80,745 | $8.26 | $666,953.70 |
DisclosureSEC source: 0001869206-25-000009 · wk-form4_1760734338.xml · nonDerivative · entry 2 Ellenbogen Michael · CIK 0001869206 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,083,961 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on June 12, 2025. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.03 to $8.54. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 15, 2025 Filed Oct 17, 2025 20:52 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionClass A Common Stock | 80,745 | $0.24 | $19,378.80 |
DisclosureSEC source: 0001869206-25-000009 · wk-form4_1760734338.xml · nonDerivative · entry 1 Ellenbogen Michael · CIK 0001869206 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,164,706 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 15, 2025 Filed Sep 17, 2025 20:02 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionStock Option (Right to Buy) · Derivative | 80,745 | $0.00 Strike: $0.24 | $0.00 |
DisclosureSEC source: 0001869206-25-000006 · wk-form4_1758139356.xml · derivative · entry 4 Ellenbogen Michael · CIK 0001869206 · Director · Founder & Chief Innovation Ofc 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,623,719 Underlying: Class A Common Stock · 80,745 shares Expires 2027-09-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested and became exercisable as to 25% on January 31, 2018 and vested in 36 equal monthly installments thereafter. Read SEC document |
| September 15, 2025 Filed Sep 17, 2025 20:02 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | SaleClass A Common Stock | 80,745 | $8.46 | $683,102.70 |
DisclosureSEC source: 0001869206-25-000006 · wk-form4_1758139356.xml · nonDerivative · entry 2 Ellenbogen Michael · CIK 0001869206 · Director · Founder & Chief Innovation Ofc 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,083,961 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on June 12, 2025. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.34 to $8.80. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 15, 2025 Filed Sep 17, 2025 20:02 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionClass A Common Stock | 80,745 | $0.24 | $19,378.80 |
DisclosureSEC source: 0001869206-25-000006 · wk-form4_1758139356.xml · nonDerivative · entry 1 Ellenbogen Michael · CIK 0001869206 · Director · Founder & Chief Innovation Ofc 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,164,706 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 23, 2025 Filed Jun 25, 2025 21:15 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | OtherClass A Common Stock | 2,259,987 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-033044 · wk-form4_1750886104.xml · nonDerivative · entry 1 Ellenbogen Michael · CIK 0001869206 · Director · Founder & Chief Innovation Ofc 10b5-1 filing: No plan indicated Ownership: Indirect · Held by E Ventures Trust Disclosed balance after: 0 F1 · kind: Reflects shares of the Company's common stock held by the E Ventures Trust dated September 12, 2019. The Reporting Person held investment control over all shares held by such trusts until June 23, 2025, on which date investment control over such trust was transferred to an independent investment advisor. As a result, the Reporting Person no longer has beneficial ownership of such shares and the shares will not be included in the Reporting Person's future Section 16 reports. Read SEC document |
| March 03, 2025 Filed Mar 4, 2025 21:11 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | GrantRestricted Stock Units · Derivative | 113,636 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-009839 · wk-form4_1741122663.xml · derivative · entry 11 Ellenbogen Michael · CIK 0001869206 · Director · Founder & Chief Innovation Ofc 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 113,636 Underlying: Class A Common Stock · 113,636 shares Expires not disclosed F3 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A common stock. The RSUs have no expiration date. F8 · derivative.exercise_date: The RSUs vest based on the achievement of certain specified Company stock price goals during a three-year performance period, subject to the Reporting Person's continuous employment with the Company through the date that the Board of Directors or Compensation Committee, as applicable, certifies the total number of RSUs earned. F3 · derivative.expiration_date: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A common stock. The RSUs have no expiration date. Read SEC document |
| March 03, 2025 Filed Mar 4, 2025 21:11 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | GrantRestricted Stock Units · Derivative | 151,515 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-009839 · wk-form4_1741122663.xml · derivative · entry 10 Ellenbogen Michael · CIK 0001869206 · Director · Founder & Chief Innovation Ofc 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 151,515 Underlying: Class A Common Stock · 151,515 shares Expires not disclosed F3 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A common stock. The RSUs have no expiration date. F7 · derivative.exercise_date: The RSUs vest in three equal tranches on the first, second, and third anniversaries of the grant date, subject to the Reporting Person's continued employment with the Company through each vesting date. F3 · derivative.expiration_date: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A common stock. The RSUs have no expiration date. Read SEC document |
| March 03, 2025 Filed Mar 4, 2025 21:11 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | SaleClass A Common Stock | 56,263 | $3.30 | $185,667.90 |
DisclosureSEC source: 0001628280-25-009839 · wk-form4_1741122663.xml · nonDerivative · entry 4 Ellenbogen Michael · CIK 0001869206 · Director · Founder & Chief Innovation Ofc 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,083,961 F1 · shares: The sale reported in the Form 4 was effected solely with the intent to cover withholding taxes in connection with the vesting of RSUs. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.27 to $3.30. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 21:11 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionRestricted Stock Units · Derivative | 57,392 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-009839 · wk-form4_1741122663.xml · derivative · entry 9 Ellenbogen Michael · CIK 0001869206 · Director · Founder & Chief Innovation Ofc 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 114,784 Underlying: Class A Common Stock · 57,392 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A common stock. The RSUs have no expiration date. F6 · derivative.exercise_date: The RSUs vest in three equal annual installments commencing on March 1, 2025. F3 · derivative.expiration_date: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A common stock. The RSUs have no expiration date. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 21:11 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionRestricted Stock Units · Derivative | 66,767 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-009839 · wk-form4_1741122663.xml · derivative · entry 8 Ellenbogen Michael · CIK 0001869206 · Director · Founder & Chief Innovation Ofc 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,787 Underlying: Class A Common Stock · 66,767 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A common stock. The RSUs have no expiration date. F5 · derivative.exercise_date: The RSUs vest in three equal annual installments commencing on March 1, 2024. F3 · derivative.expiration_date: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A common stock. The RSUs have no expiration date. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 21:11 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionRestricted Stock Units · Derivative | 47,765 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-009839 · wk-form4_1741122663.xml · derivative · entry 7 Ellenbogen Michael · CIK 0001869206 · Director · Founder & Chief Innovation Ofc 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 47,765 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A common stock. The RSUs have no expiration date. F4 · derivative.exercise_date: The RSUs vest in three equal annual installments commencing on March 1, 2023. F3 · derivative.expiration_date: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A common stock. The RSUs have no expiration date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.